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Objectives: Overexpression of efflux pumps in Acinetobacter baumannii is a common mechanism of multidrug
resistance in this nosocomial pathogen. Increased efflux pump expression is often assumed from MICs of anti-
biotics and dyes, without measurement of efflux levels. This study describes a safe, rapid and simple 96-well
plate assay that measures the accumulation of a fluorescent dye, Hoechst (H) 33342.
Methods: The growth kinetics of three resistant and three susceptible Singaporean clinical isolates of
A. baumannii in the presence of carbonyl cyanide-m-chlorophenylhydrazone (CCCP) and phenylalanine-
arginine-b-naphthylamide (PAbN) were studied to determine non-inhibitory concentrations for use in the
assay. Accumulation of H33342 was measured in these clinical isolates with and without efflux inhibitors.
Accumulation was also measured in an adeB efflux pump deletion mutant and its parental strain to assess
the ability of the assay to identify altered efflux in strains lacking efflux pumps. Results were compared with
data from accumulation assays with ethidium bromide and norfloxacin.
Results: Increased accumulation, indicative of reduced efflux, was observed in AB211DadeB compared with
parental strain AB211. Clinical isolates demonstrated different levels of accumulation of H33342. The addition
of both CCCP and PAbN significantly increased the accumulation of H33342. The pattern of norfloxacin accu-
mulation broadly reflected H33342 accumulation. Ethidium bromide showed a different pattern of accumula-
tion in clinical isolates.
Conclusions: The measurement of the intracellular accumulation of H33342 in real time allowed a comparison
of efflux activity between strains of A. baumannii.
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Introduction
Acinetobacter baumannii is a Gram-negative nosocomial patho-
gen, capable of causing opportunistic infections such as pneu-
monia, skin and soft tissue infections, urinary tract infections
and bacteraemia in immunocompromised patients, particularly
those in the intensive care unit. Isolates are often multidrug1
or even pan-drug2 resistant and are able to resist desiccation;
therefore, they persist for long periods of time in the hospital en-
vironment.3,4 As a consequence, this pathogen poses a major
threat to human health worldwide.
A. baumannii exhibits intrinsic multiple drug resistance (MDR)
to a range of antibiotics due to chromosomally encoded
enzymes, an innate expression of efflux pumps and low
membrane permeability. Various chromosomally encoded
efflux systems and outer membrane porins (OMPs) have been
identified as contributing to MDR in A. baumannii.5 Best charac-
terized is the AdeABC resistance–nodulation–division (RND)
family system, first identified in A. baumannii BM4454, an MDR
clinical isolate. adeABC is overexpressed in some clinical isolates
and is associated with resistance to aminoglycosides, b-lactams,
fluoroquinolones, tetracyclines, tigecycline, macrolides, chloram-
phenicol and trimethoprim.6,7 In BM4454, another RND system,
AdeIJK, gives innate MDR and has a different substrate range
from AdeABC.8 When adeIJK is inactivated, the MICs of b-lactams,
fluoroquinolones, tetracyclines, tigecycline, lincosamides, rifampi-
cin, chloramphenicol, co-trimoxazole, novobiocin and fusidic
acid are decreased, while susceptibility to aminoglycosides is
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unaffected.8,9 The AdeFGH RND system, also identified in BM4454
by the Courvalin team, confers MDR when overexpressed, but did
not contribute to innate resistance to the antibiotics tested.9,10 In-
activation of AdeFGH decreased the MICs of fluoroquinolones,
chloramphenicol, trimethoprim, clindamycin, tetracyclines, tige-
cycline and sulfamethoxazole, but not of aminoglycosides or
b-lactams.10 There are also several other chromosomally
encoded non-RND efflux pumps in A. baumannii, such as CraA in
strain ATCC 19606,11 AmvA in clinical isolate AC0037,12 AbeM in
ATCC 1960613 and AbeS in AC0037.14
Compared with other Gram-negative bacteria, Acinetobacter
species possess a relatively small number of OMPs with porin-like
activity. The expression of OMPs can be regulated in response to
antibiotic stress and confer MDR. For example, membrane ex-
pression of OmpA38, OmpA32, CarO and OmpW in an MDR
strain highly resistant to tetracycline, DU202, has been shown
to decrease in the presence of sub-MIC levels of tetracycline.15
Reduced expression of OMPs has been observed in MDR clinical
isolates worldwide and may contribute towards resistance to
carbapenems. A reduction in the expression of OMPs has been
seen in imipenem-resistant clinical isolates with no identified
efflux mechanisms.16–18
Levels of efflux and membrane permeability in A. baumannii
are often inferred from the MICs of antibiotics, and changes in
pump expression are assumed without direct measurement. Cel-
lular accumulation of antibiotics in Gram-negative bacteria has
previously been assessed using radiochemical and fluorescent
techniques.19,20 Accumulation of ethidium bromide has been
measured in A. baumannii using a fluorometric assay to assess
the contribution of efflux pumps to antibiotic accumulation
and drug susceptibility.7 Ethidium bromide is a DNA intercalating
dye; its fluorescence increases when intercalating with DNA, and
this feature can be used to differentiate between intracellularly
and extracellularly located compound. However, problems have
been identified with the use of ethidium bromide as an indicator
of cellular accumulation. The compound gives a low quantum
yield and is self-quenching at high intracellular levels, so cellular
accumulation can appear lower than it actually is.21 In addition,
ethidium bromide is toxic and its use in laboratories is being
phased out. Therefore, a safe, rapid and easy method is needed
to measure accumulation in A. baumannii and provide reliable in-
formation on levels of efflux and membrane permeability in this
organism.
The bis-benzamide dye Hoechst (H) 33342 is a fluorescent dye
that is readily taken up by living cells and fluoresces with a high
quantum yield upon binding to DNA and when in the hydropho-
bic environment of the lipid membrane. It displays low toxicity
and low mutagenicity when used at a concentration of
10 mM,22 making it an ideal fluorescent probe for the measure-
ment of cellular accumulation. H33342 has been used to charac-
terize membrane transport activity in mammalian cells23 and
Lactococcus lactis,24 to investigate the contribution of the ABC
efflux pump VcaM to MDR in Vibrio cholerae25 and to assess
efflux activity in Escherichia coli and Salmonella enterica.25 Previ-
ously in this laboratory, an assay of H33342 accumulation was
developed as a single, rapid test for MDR Gram-negative Entero-
bacteriaceae.26 In the present study, the H33342 accumulation
assay was adapted for use with A. baumannii and accumulation
was studied in several MDR A. baumannii clinical isolates and
efflux pump gene-deletion mutants.
Methods
Strains, media and chemicals
Nine strains of A. baumannii were used throughout. AB211 is a
tigecycline-resistant, post-therapy clinical isolate and AB211DadeB is a
mutant created by Hornsey et al.27 by insertional inactivation of adeB
in AB211. S1, S2, S3, R1, R2 and R3 were provided by the Network for Anti-
microbial Resistance Surveillance (Singapore) as clinical isolates that
showed an antibiotic resistance profile similar to highly resistant (R)
and more susceptible (S) isolates found causing infection in Singaporean
hospitals (see Table 1). AYE was used as a reference MDR strain; bioinfor-
matic analyses revealed that AYE was representative of A. baumannii as it
contained all previously described efflux pump genes and the majority of
predicted efflux pumps (AciBASE: http://acinetobacter.bham.ac.uk;
L. Evans and L. J. V. Piddock, unpublished data). All clinical isolates and
AYE were confirmed as A. baumannii using a gyrB multiplex PCR.28,29 All
strains were routinely cultured on Luria-Bertani (LB) agar and in LB
broth. All chemicals were from Sigma–Aldrich (Poole, Dorset, UK).
Determination of MICs and H33342 toxicity
The MICs of antibiotics and efflux inhibitors (EIs) were determined by the
agar doubling dilution method according to BSAC standard method-
ology.30 The MICs of imipenem and meropenem were determined by
Etest (bioMe´rieux, Hampshire, UK). Resistance was determined using
BSAC-recommended breakpoints for A. baumannii. Where MIC break-
points were unavailable, EUCAST non-species-specific breakpoints were
used. MDR was defined as resistance to three or more antimicrobial
classes. Toxicity of H33342 was determined by overnight incubation of
1 mL of S1–S3 and R1–R3 at mid-logarithmic growth phase [optical
density (OD) at 600 nm of 0.6] at 378C on agar containing doubling con-
centrations of H33342.
Growth kinetics
Bacterial strains were grown with aeration in LB broth at 378C overnight.
A 4% inoculum (120 mL in 3 mL) of bacterial culture was added to fresh
LB broth. This suspension was incubated with aeration at 378C until the
cells reached an OD at 600 nm of 0.6 (¼108 cfu/mL). Cells were harvested
by centrifugation at 2200 g for 10 min at room temperature and resus-
pended in 3 mL of sterile LB broth. The OD at 600 nm of the suspension
was measured and adjusted to 0.5 to standardize the number of cells in
each culture and to simulate the conditions used in the H33342 accumu-
lation assay. An aliquot of 196 mL of this suspension was added to each
well of a clear 96-well microtitre tray, along with 4 mL of EI at the
required concentration (see the Results section). The OD at a wavelength
of 600 nm was measured over 16 h in a BMG FLUOstar Optima (BMG,
Aylesbury, UK) at 378C. Each experiment included three biological repli-
cates and three technical replicates for each bacterial strain. The FLUOs-
tar is sensitive to an OD at 600 nm of between 0.0 and 4.0, and
reproducibility is +0.010 for the OD range 0.0–2.0 (www.bmglabtech.
com). The difference in final OD at 16 h was calculated, and values
returning a P value of ≤0.05 from a Student’s t-test were taken as
significant.
Accumulation assays of H33342, ethidium bromide and
norfloxacin
The H33342 bis-benzamide assay was carried out as described by
Coldham et al.,26 with the following modifications; strains were grown
to an OD at 600 nm of 0.6 and, once resuspended in PBS at room tem-
perature, were adjusted to an OD at 600 nm of 0.1, 0.2, 0.3 or 0.5. Cen-
trifugation steps were carried out at 2200 g. The wells of a black
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microtitre tray (Corning, Amsterdam, The Netherlands) were inoculated
with either 180 mL of cell suspension or 176 mL of cell suspension with
4 mL of the EI carbonyl cyanide-m-chlorophenyl hydrazone (CCCP) or
phenylalanine-arginine-b-naphthylamide (PAbN) at the required concen-
tration (see the Results section). Fluorescence was measured and data
were analysed as previously described.26 The level at which maximum
fluorescence was reached and remained unchanged within the time
period of the assay was taken as the steady-state accumulation level.
In order to quantitatively compare the efflux rate of the strains, the
time needed for a 4-fold increase in dye fluorescence after H33342 injec-
tion was calculated. Each assay was repeated three times with three bio-
logical replicates. Differences in accumulation between clinical isolates
and AYE were analysed for statistical significance using Student’s t-test;
a P value ≤0.05 was considered significant.
Ethidium bromide assays were carried out essentially as the H33342
accumulation assays described above, except that cultures were resus-
pended in 1 M sodium phosphate buffer with 5% glucose. A 1 mM eth-
idium bromide stock solution was prepared and 20 mL was injected to
give a final concentration of 0.1 mM in the assay. Fluorescence was mea-
sured over 117 min at excitation and emission wavelengths of 530 nm
and 600 nm, respectively, in a FLUOstar Optima. Norfloxacin assays
were carried out as previously by Mortimer and Piddock.31
Results
Phenotypic characterization of strains
AYE, R1, R2 and R3 were MDR clinical isolates, with resistance to
more than three classes of antibiotics including b-lactams (in-
cluding carbapenems), fluoroquinolones and aminoglycosides.
Isolate R2 was also resistant to colistin. Strain AYE and isolates
R2 and R3 were resistant to tigecycline. Isolates S1, S2 and S3
were resistant to fewer antibiotics; S1 and S3 were susceptible
to ciprofloxacin, S2 and S3 were susceptible to colistin, S1 was
susceptible to tigecycline and S1, S2 and S3 were susceptible
to carbapenems (Table 1).
Growth in the presence of EIs and toxicity of H33342
To determine non-inhibitory concentrations of EIs for use in the
H33342 accumulation assay, the MICs of CCCP and PAbN for
strain AYE and isolates S1–S3 and R1–R3 were determined.
For all isolates other than S3, the MICs of CCCP and PAbN were
256 and 1024 mg/L. The MICs of CCCP and PAbN were one dilu-
tion lower for isolate S3. Growth kinetics in the presence of
sub-MIC concentrations of EIs were then assessed to simulate
conditions in the H33342 accumulation assay and ensure no in-
hibition of growth. Concentrations of EIs that did not restrict
growth in the 2 h time period of the H33342 accumulation
assay were used in all experiments. Concentrations of 50 mM
CCCP and 100 mM PAbN had no effect on growth under condi-
tions used in the H33342 assay (data not shown). The MICs of
H33342 and ethidium bromide were .256 mg/L for all isolates.
H33342 can be used to determine efflux in A. baumannii
Previous work in this laboratory has shown that different levels of
accumulation of H33342 can be distinguished for different
strains of Enterobacteriaceae with an H33342 concentration of
2.5 mM.26 With the A. baumannii isolates studied, accumulation
of 2.5 mM H33342 with cultures at an OD at 600 nm of 0.5
was able to detect different levels of accumulation. Heat-killed
cells, which rapidly accumulate H33342, were included as a
maximum fluorescence level control.
The ability of the assay to identify altered efflux in strains lacking
efflux pumps was assessed with AB211 and AB211DadeB.
AB211DadeB contains an inactivated adeB gene, which encodes
the inner membrane component of the AdeABC RND efflux
pump. Previous studies have shown that this efflux pump deletion
mutant is inhibitedbya lowerconcentrationof tigecycline than the
parental strain.27 AB211DadeB accumulated H33342 at an
increased rate, with a 4-fold fluorescence increase reached
at 331 s after injection compared with 1656 s in the parental
strain. The steady-state level of H33342 was also significantly
higher in themutantwhencomparedwith theparental strain, sug-
gesting a reduced level of efflux (Figure 1).
When data for the clinical isolates were compared with those
for AYE, differing levels of accumulation were seen for isolates
S1–S3, R1 and R2 (Figure 2a). S1, S3, R1 and R2 showed significant-
ly higher levels of accumulation of H33342 than AYE, whereas
isolate S2 accumulated significantly lower levels of H33342 when
compared with AYE. Levels of norfloxacin accumulated in the clin-
ical isolates followed the same pattern as H33342 accumulation.
Table 1. MIC values of clinically relevant antibiotics for A. baumannii (mg/L)
Strain NAL CIP KAN GEN CAZ IPMa MEMa PIP AMP AMP+SUL CHL TGC TET ERY CST TMP
AYE .1024 128 .1024 1024 .1024 0.38 .32 512 512 32 512 2 .1024 512 2 .1024
S1 8 0.5 1 ,2 .1024 0.094 0.38 ,2 32 8 128 0.12 4 8 8 16
S2 32 16 512 2 .1024 0.094 0.5 64 512 64 128 2 16 16 1 8
S3 32 0.5 1 64 .1024 0.094 0.25 32 512 64 128 2 8 8 2 32
R1 1024 8 .1024 .1024 .1024 .32 .32 512 512 32 256 0.5 .1024 512 2 32
R2 .1024 256 .1024 .1024 .1024 .32 .32 256 1024 64 128 1 1024 512 4 128
R3 1024 128 .1024 256 .1024 .32 .32 1024 1024 64 256 2 .1024 1024 2 128
NAL, nalidixic acid; CIP, ciprofloxacin; KAN, kanamycin; GEN, gentamicin; CAZ, ceftazidime; IPM, imipenem; MEM, meropenem; PIP, piperacillin, AMP,
ampicillin; AMP+SUL, ampicillin+sulbactam; CHL, chloramphenicol; TGC, tigecycline; TET, tetracycline; ERY, erythromycin; CST, colistin; TMP,
trimethoprim.
aMIC values determined by Etest.
Measurement of efflux in Acinetobacter
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H33342 accumulation in the presence of EIs
The contribution of different classes of efflux pump to the accu-
mulation of H33342 in strain AYE and clinical isolates S1–S3 and
R1–R3 was further investigated with the addition of EIs. The fold
change in fluorescence in the steady-state phase+the addition
of EIs was calculated for each isolate.
Addition of CCCP caused a significant increase (P≤0.05) in the
level of H33342 accumulated at steady-state for all isolates with
the largest fold changes of 2.15 and 2.00 seen in isolates S2 and
R3, respectively (Figure 2b). Isolates S1, S3, R1 and R2 and strain
AYE showed fold increases in H33342 accumulation of 1.42–
1.80.
Addition of PAbN caused the largest increase in accumulation
of H33342 in isolate S3, with a fold change of 1.89 (Figure 2b).
There was also a significant increase in accumulation in all
other isolates, but the increase was generally significantly
greater in the presence of CCCP.
Ethidium bromide accumulation
To make a comparison with data obtained with H33342, accu-
mulation of ethidium bromide was measured as it is possible
that ethidium bromide may be a substrate for different efflux
pumps. Isolates S1–S3 and R1–R3 all showed a significant dif-
ference in accumulation of ethidium bromide compared with ref-
erence strain AYE (Figure 3a). R1 and R2 showed less
accumulation than S1–S3. Isolate R3 and strain AYE accumu-
lated more ethidium bromide than R1 and R2, similar to that
seen for isolates S1–S3.
Addition of CCCP caused a significant increase (P≤0.05) in the
level of ethidium bromide accumulated at steady-state for strain
AYE and isolates R1 and R2, with a 1.54-, 1.60- and 2.59-fold in-
crease, respectively (Figure 3b). Addition of CCCP had a smaller
effect on the level of ethidium bromide accumulated in S1,
with a 1.10-fold increase observed. CCCP had no effect on the
level of ethidium bromide accumulated in S2, S3 and R3.
Addition of PAbN also significantly increased (P≤0.05) the
level of ethidium bromide accumulated in AYE, R1 and R2, with
a 1.2-fold increase in strain AYE and a 1.4-fold increase in both
R1 and R2 (Figure 3b). PAbN had no effect on the accumulation
of ethidium bromide by isolates S1, S2, S3 and R3.
Discussion
Increased efflux as a result of overexpression of efflux pumps is a
common mechanism of MDR in A. baumannii, and resistance to
a wide range of antibiotics can arise from a single mutation in a
gene.6 An increase in the MIC of a number of different classes of
antibiotics is often assumed to be the result of an overexpression
of efflux pumps, but levels of efflux are not always directly
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Figure 1. Accumulation of H33342 by AB211 and AB211DadeB. Data
displayed are a representative example of at least three separate
experiments.
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Figure 2. (a) Steady-state levels of accumulation of H33342 by strain AYE and clinical isolates S1, S2, S3, R1, R2 and R3 at 117 min of exposure.
*Significant differences in value for the clinical isolates compared with AYE, indicating values returning a P value of ≤0.05 from a Student’s t-test.
(b) Fold difference in levels of H33342 accumulated by AYE and clinical isolates S1, S2, S3, R1, R2 and R3 at steady-state+EI. *Significant
differences in value in the presence of EI compared with the absence of EI, indicating values returning a P value of ≤0.05 from a Student’s t-test.
Data are displayed as a representative example of at least three separate experiments. The standard deviations represent variations between
three biological replicates.
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measured. A sensitive and specific method is needed so that
changes in efflux can be measured safely, quickly and simply.
Measurement of the accumulation of H33342 provides a
means of characterizing MDR strains of A. baumannii and asses-
sing the role of efflux in antibiotic resistance. The assay is carried
out in a 96-well plate and provides a rapid and easy way of infer-
ring levels of efflux by measuring the accumulation of a fluores-
cent dye. Further assessment of the role of efflux in MDR can be
investigated with the addition of EIs to inhibit different classes
of efflux pump. This method can also be used to determine
whether alterations in outer membrane permeability contribute
to the phenotype as changes in dye accumulation due to
altered outer membrane protein levels can be assessed.26
This study demonstrates the suitability of the H33342
accumulation assay, previously developed in this laboratory to
measure H33342 accumulation in Enterobacteriaceae,26 for
use with A. baumannii. The H33342 assay revealed differences
in levels of accumulation between AYE and five of the six clinical
isolates tested.
The addition of EIs highlighted the contribution of different
classes of efflux pump to efflux levels in isolates. In AYE, a previ-
ously characterized MDR isolate, the addition of CCCP, which
dissipates the proton motive force required by several efflux
pumps, caused a significant increase in H33342 accumulation,
suggesting reduced efflux due to the inhibition of active efflux.
The addition of PAbN, which inhibits RND transporters such
as Pseudomonas aeruginosa MexAB32 and E. coli AcrB,33 also
resulted in higher levels of H33342 accumulation, i.e. reduced
levels of efflux. However, this reduction was not as great as
that seen with CCCP, suggesting that RND pumps contribute to
efflux in AYE or that CCCP perturbs other cellular activities, as
found by Henderson.34
Accumulation of H33342 also detected a significant differ-
ence in dye accumulation in an efflux pump mutant (Figure 1)
compared with the parental strain. AB211DadeB, which lacks
the RND pump AdeABC due to deletion of adeB, accumulated
a much higher level of dye than the parental strain AB211.
This effect has been previously shown in the adeB mutant,
BM4454-1, and its parental strain, BM4454, using an ethidium
bromide accumulation assay.7
The level of H33342 accumulated at steady-state did not
always correlate with the MICs of antibiotics for the clinical iso-
lates. It was hypothesized that strains exhibiting higher MICs of
antibiotics would display increased levels of efflux, thus account-
ing, in part, for their MDR phenotype. A. baumannii has been
shown to possess various different antibiotic resistance mechan-
isms.5 However, the clinical isolates also possessed numerous
antibiotic resistance genes, including tem, oxa, ampC and aph,
and these presumably mask the effect of efflux on the pheno-
type when measured by MIC.
Comparison of the accumulation of H33342 and ethidium
bromide in the clinical isolates of A. baumannii revealed different
patterns of accumulation of the dyes, suggesting that these two
compounds might be substrates for different pumps. Low levels
of accumulation of ethidium bromide in isolates R1 and R2
suggest higher levels of efflux and may provide an explanation
for the MDR phenotype displayed by these isolates. It may be
that ethidium bromide and antibiotics tested in this study are sub-
strates for some of the same efflux pumps. In the presence of
CCCP, the efflux of ethidium bromide was most affected in strain
AYE and isolates R1 and R2. This was not surprising as these clin-
ical isolates showed the highest level of efflux of this dye. The pres-
ence of CCCP gave no significant decrease in efflux in isolates R3
and S2, the isolates that showed the least ethidium bromide
efflux. Interestingly, these two isolates were those that showed
the highest levels of efflux of H33342 and displayed the largest
decrease in efflux of this dye with the addition of CCCP. This sug-
gests that clinical isolates of A. baumannii produce efflux pumps
with different substrate specificities and these may be at different
levels. The addition of PAbN affected the efflux of ethidium
bromide in a similar way to CCCP, although the increase in accu-
mulation was not as high as that seen with CCCP.
*
* *
*
*
*
*
2.5
3.0(b)
2.0
1.5
1.0
0.5
0
Fo
ld
 c
ha
ng
e
AYE S1 S2
No EI CCCP PAβN
S3 R1 R2 R3
1800
1600
*
*
*
*
**
(a)
1400
Fl
uo
re
sc
en
ce
1200
1000
800
600
400
200
0
AYE S1 S2 S3 R1 R2 R3
Figure 3. (a) Steady-state levels of accumulation of ethidium bromide by strain AYE and clinical isolates S1, S2, S3, R1, R2 and R3 at 117 min of
exposure. *Significant differences in value for the clinical isolates compared with AYE, indicating values returning a P value of ≤0.05 from a
Student’s t-test. (b) Fold difference in levels of ethidium bromide accumulated by AYE and clinical isolates S1, S2, S3, R1, R2 and R3 at
steady-state+EI. *Significant differences in value in the presence of EI compared with the absence of EI, indicating values returning a P value of
≤0.05 from a Student’s t-test. Data are displayed as a representative example of at least three separate experiments. The standard deviations
represent variations between three biological replicates.
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In summary, the H33342 accumulation assay previously
developed for assessment of cellular permeability in Enterobac-
teriaceae has been adapted to provide a safe, cheap, rapid
and sensitive test for the measurement of accumulation in
A. baumannii. This assay can be used to compare clinical isolates
of A. baumannii and assess the role of individual efflux pumps or
other proteins by comparing deletion mutants with their parental
strain. Using EIs, the accumulation of H33342 can be used to
evaluate the contribution of efflux pumps to the MDR phenotype
commonly seen in clinical isolates. However, the disparity
between data acquired with H33342 and ethidium bromide
emphasizes the need to use more than one substrate to
measure efflux when researching the role of efflux in MDR.
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